A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization (Q46048397)

19 December 2017

title

A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization. (English)

1 reference

19 December 2017

0 references

West JA

1

1 reference

19 December 2017

Miller NH

2

1 reference

19 December 2017

Parker KM

3

1 reference

19 December 2017

Senneca D

4

1 reference

19 December 2017

Ghandour G

5

1 reference

19 December 2017

Clark M

6

1 reference

19 December 2017

Greenwald G

7

1 reference

19 December 2017

Heller RS

8

1 reference

19 December 2017

Fowler MB

9

1 reference

19 December 2017

DeBusk RF

10

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

19 December 2017

American Journal of Cardiology

published in

1 reference

19 December 2017

volume

79

1 reference

19 December 2017

issue

1

1 reference

19 December 2017

page(s)

58-63

1 reference

19 December 2017

Prevalence and mortality rate of congestive heart failure in the United States

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900676-5

Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900676-5

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900676-5

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900676-5

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900676-5

Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900676-5

Perspective of the pharmaceutical industry on the development of new drugs for heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900676-5

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900676-5

Difference in mortality between patients treated with captopril or enalapril in the xamoterol in severe heart failure study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900676-5

Early readmission of elderly patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900676-5

Understanding and Improving Patient Compliance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900676-5

Intensive home-care surveillance prevents hospitalization and improves morbidity rates among elderly patients with severe congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900676-5

A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900676-5

A case-management system for coronary risk factor modification after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900676-5

Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900676-5

A brief self-administered questionnaire to determine functional capacity (The Duke Activity Status Index)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900676-5

The MOS 36-ltem Short-Form Health Survey (SF-36)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900676-5

Smoking cessation after acute myocardial infarction: effects of a nurse-managed intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900676-5

10.1016/S0002-9149(96)00676-5

7 January 2021

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

9024737

1 reference

19 December 2017